In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

Is TMDX a good stock to buy? We came across a bullish thesis on TransMedics Group, Inc. on The Cash Flow Compounder’s ...

The Touchstone Mid Cap Fund (Class A Shares, Load Waived) outperformed its benchmark, the Russell MidCap® Index, for the ...

New design, verification and simulation solutions to re-engineer AI-powered product innovation at Synopsys Converge 2026.

Rewey Asset Management, an investment management firm, released its “RAM Smid Composite” investor letter for the fourth quarter of 2025. A copy of the letter can be downloaded here. In Q4 2025, the ...

Artificial intelligence and machine learning (AI/ML) are no longer emerging capabilities inside enterprise environments. In ...

All the main Adobe software programs and what to use them for.

Nvidia’s new DLSS 5 uses generative AI and structured graphics data to make video games more realistic. CEO Jensen Huang says ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established constraints. Generative AI turns that on its head. It is an expansive force, ...

For a decade and a half now, my work has fallen into two categories: collecting evidence on the threat posed by fossil fuels, and deploying written and spoken words to urge action against it. Recently ...

The application of artificial intelligence (AI) in drug discovery is revolutionizing the field, offering unprecedented opportunities for accelerating the ...

On Feb. 20, the Center for Human-Computer Interaction + Design convened an interdisciplinary group to discuss the validity and trustworthiness of social and behavioral data simulated by large language ...